
Sign up to save your podcasts
Or


In part one of this two-part series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss what disease-modifying therapies can be safely continued and strategically timed when pregnancy is anticipated.
Show citation:
Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi:10.1212/WNL.0000000000213907
By American Academy of Neurology4.8
129129 ratings
In part one of this two-part series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss what disease-modifying therapies can be safely continued and strategically timed when pregnancy is anticipated.
Show citation:
Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi:10.1212/WNL.0000000000213907

497 Listeners

302 Listeners

49 Listeners

290 Listeners

3,343 Listeners

261 Listeners

12 Listeners

23 Listeners

195 Listeners

513 Listeners

364 Listeners

6,420 Listeners

180 Listeners

371 Listeners

80 Listeners